These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7496132)
1. Circulating blood group related carbohydrate antigens as tumour markers. Orntoft TF; Bech E Glycoconj J; 1995 Jun; 12(3):200-5. PubMed ID: 7496132 [TBL] [Abstract][Full Text] [Related]
2. Activation of Thomsen-Friedenreich antigen on red cells: a possible source of errors in antigen typing with some monoclonal antibodies. Písacka M; Stambergová M Vox Sang; 1994; 66(4):300. PubMed ID: 8079458 [No Abstract] [Full Text] [Related]
8. Expression of blood group-related carbohydrate antigens in normal human pancreatic tissue. Philipsen EK; Jørgensen M; Dabelsteen E APMIS; 1991 Oct; 99(10):931-40. PubMed ID: 1930966 [TBL] [Abstract][Full Text] [Related]
9. Serological tumor markers for monitoring breast cancer. Sölétormos G Dan Med Bull; 2001 Nov; 48(4):229-55. PubMed ID: 11767127 [No Abstract] [Full Text] [Related]
10. Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions. Stenersen TC; Dabelsteen E APMIS Suppl; 1992; 27():139-48. PubMed ID: 1520523 [TBL] [Abstract][Full Text] [Related]
11. Serum (circulating) tumor markers for breast cancer. Hayes DF Recent Results Cancer Res; 1996; 140():101-13. PubMed ID: 8787054 [TBL] [Abstract][Full Text] [Related]
12. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247 [TBL] [Abstract][Full Text] [Related]
13. Altered expression of ABO (H) carbohydrate antigens is seen in pleomorphic adenomas. Therkildsen MH; Mandel U; Christensen M; Barfoed C; Dabelsteen E APMIS; 1992 May; 100(5):415-23. PubMed ID: 1375034 [TBL] [Abstract][Full Text] [Related]
14. Cell type-dependent alterations of binding of synthetic blood group antigen-related oligosaccharides in lung cancer. Kayser K; Bovin NV; Zemlyanukhina TV; Donaldo-Jacinto S; Koopmann J; Gabius HJ Glycoconj J; 1994 Aug; 11(4):339-44. PubMed ID: 7873930 [TBL] [Abstract][Full Text] [Related]
15. Simple mucin-type carbohydrate antigens in pleomorphic adenomas. Therkildsen MH; Mandel U; Christensen M; Clausen H; Dabelsteen E APMIS; 1993 Mar; 101(3):242-8. PubMed ID: 8389564 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer and tumor markers: role of the newly identified CAR-3 antigen. Giulianotti PC; Boggi U; Ferdeghini M; Di Candio G; Caravaglios G; Bellini R; Mosca F Ann Ital Chir; 1997; 68(3):307-13. PubMed ID: 9419908 [TBL] [Abstract][Full Text] [Related]
19. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score. Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488 [TBL] [Abstract][Full Text] [Related]
20. The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass. Schutter EM; Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P; Verheijen RH Am J Obstet Gynecol; 2002 Aug; 187(2):385-92. PubMed ID: 12193930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]